Novo Nordisk haemophilia drug moves closer to approval in Japan

COPENHAGEN Mon Nov 18, 2013 5:58am EST

Related Topics

COPENHAGEN Nov 18 (Reuters) - NovoEight, a haemophilia drug made by Denmark's Novo Nordisk, is a step closer to marketing approval in Japan after it passed a review by the country's drugs committee.

Novo, the world's biggest insulin producer, said in a statement on Monday that it expects to receive marketing authorisation within a few months.

The remaining step in the regulatory process is an official approval from the Ministry of Health, Labour and Welfare, to which the Committee on Drugs serves as an advisory body. (Reporting by Mette Fraende; Editing by David Goodman)

A couple walks along the rough surf during sunset at Oahu's North Shore, December 26, 2013. REUTERS/Kevin Lamarque

Find your dream retirement town

Florida? Hawaii? Reuters has teamed up with Zillow to give you the power to customize a list of your best places to retire.  Video | Full Article